華泰證券(06886.HK):為境外全資附屬公司發行1億美元債券提供擔保
格隆匯 4 月 21日丨華泰證券(06886.HK)公佈,公司境外全資子公司華泰國際金融控股有限公司(以下簡稱"華泰國際")旗下附屬公司Pioneer Reward Limited發行了期限三年、金額1億美元的固定利率美元債券。該次債券是在2021年4月9日發行的13億美元債券中三年期品種的基礎上實施的增發。除發行金額外,該次債券的其餘條款不變。公司於2021年4月20日作為擔保人與花旗國際有限公司(作為受託人)簽署擔保協議,為Pioneer Reward Limited發行的此次債券提供無條件及不可撤銷的保證擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.